Maria Gabriella Vigorita
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maria Gabriella Vigorita has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
A Trovato
Dipartmento Farmaco-biologico, Facoltà di Farmacia Università di Messina, Viale SS. Annunziata, 98168 Messina, Italy
2 shared publicationsF Monforte
Dipartimento Farmaco-chimico, Facoltà di Farmacia Università di Messina, Viale SS. Annunziata, 98168 Messina, Italy
2 shared publications- Francesco Ortuso
Dipartimento di Scienze della Salute, Università “Magna Græcia” di Catanzaro, Viale Europa, 88100 Catanzaro, Italy
2 shared publications M.F Taviano
Dipartmento Farmaco-biologico, Facoltà di Farmacia Università di Messina, Viale SS. Annunziata, 98168 Messina, Italy
2 shared publicationsM.T Monforte
Dipartmento Farmaco-biologico, Facoltà di Farmacia Università di Messina, Viale SS. Annunziata, 98168 Messina, Italy
2 shared publicationsR Maccari
Dipartimento Farmaco-chimico, Facoltà di Farmacia Università di Messina, Viale SS. Annunziata, 98168 Messina, Italy
2 shared publications
Latest Publications
- 15 December 2007
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 15 (24) , 7618-7625
Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures
- 15 December 2007
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 15 (24) , 7618-7625
Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures
- 16 May 2005
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 13 (10) , 3371-3378
Biocatalysed synthesis of β-O-glucosides from 9-fluorenon-2-carbohydroxyesters. Part 3: IFN-inducing and anti-HSV-2 properties
- 16 May 2005
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 13 (10) , 3371-3378
Biocatalysed synthesis of β-O-glucosides from 9-fluorenon-2-carbohydroxyesters. Part 3: IFN-inducing and anti-HSV-2 properties
- 24 December 2002
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 11 (6) , 999-1006
Chiral 3,3′-(1,2-Ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4-thiazolidinones] with anti-inflammatory activity. Part 11: Evaluation of COX-2 selectivity and modelling
- 24 December 2002
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 11 (6) , 999-1006
Chiral 3,3′-(1,2-Ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4-thiazolidinones] with anti-inflammatory activity. Part 11: Evaluation of COX-2 selectivity and modelling
- 1 November 2001
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 11 (21) , 2791-2794
Synthesis and antiinflammatory, analgesic activity of 3,3′-(1,2-Ethanediyl)-bis[2-aryl-4-thiazolidinone] chiral compounds. Part 10
- 1 November 2001
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 11 (21) , 2791-2794
Synthesis and antiinflammatory, analgesic activity of 3,3′-(1,2-Ethanediyl)-bis[2-aryl-4-thiazolidinone] chiral compounds. Part 10
- 11 March 2001
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 38 (2) , 485-489
Configurational assignments of the diastereomers of 3,3′‐(1,2‐ethanediyl)bis[2‐(3‐fluorophenyl)‐5‐methyl‐4‐thiazolidinone] derivative with four stereogenic centers
- 11 March 2001
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 38 (2) , 485-489
Configurational assignments of the diastereomers of 3,3′‐(1,2‐ethanediyl)bis[2‐(3‐fluorophenyl)‐5‐methyl‐4‐thiazolidinone] derivative with four stereogenic centers